Оценка влияния полиморфизма гена MDR1 на эффективность ферротерапии у пациентов с железодефицитной анемией
https://doi.org/10.37489/2588-0527-2020-2-10-11
About the Authors
И. МавляновUzbekistan
Г. Жарылкасынова
Uzbekistan
Р. Юлдашова
Uzbekistan
References
1. Kassebaum NJ, Fleming TD, Flaxman A et al. The global burden of anemia. Hematol Oncol Clin North Am. 2016;30(2):247-308. doi: 10.1016/j.hoc.2015.11.002.
2. Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol. 2011;4(3):177-184. DOI: 10.1177/1756283X11398736.
3. Zhumabayeva TN, Bazarbayeva SK, Zhilkibayeva BZh. General practice doctor’s role in diacrisis and curing of congestive heart failu. West Kazakhstan Medical journal. 2014;43(3):47-50. (In Russ).
4. Bailey RL, West KP, Black RE. The epidemiology of global micronutrient deficiencies. Ann Nutr Metab. 2015;66(2):22-33. DOI: 10.1159/000371618.
5. Armstrong GR, Summerlee AJ. The Etiology, Treatment and Effective Prevention of Iron Deficiency and Iron Deficiency Anemia in Women and Young Children Worldwide: A Review. J of Women`s Health Care. 2015;4:1. DOI: 10.4172/2167-0420.1000213.
Review
For citations:
, , . Pharmacogenetics and Pharmacogenomics. 2020;(2):10-11. (In Russ.) https://doi.org/10.37489/2588-0527-2020-2-10-11